Health

Zest Up Your Diet: Why Lemon Peel Deserves a Place on Your Plate

May 23, 2025 | 880 Views

Lemon zest, the vibrant yellow skin of lemons, is a frequently neglected source of nutrition. It provides numerous health advantages, as it is rich in antioxidants and vitamin C, along with plant substances such as flavonoids and limonene. These nutrients help to fight oxidative stress, bolster immunity, aid liver detoxification, and enhance heart health by improving blood vessel function and reducing blood pressure. Lemon zest promotes healthy skin by enhancing collagen production, alleviating inflammation associated with arthritis, and possibly aiding in cancer prevention. Thanks to its antibacterial properties, it promotes oral health; additionally, its pectin content can help with appetite control and thus assist in weight management. Rich in essential minerals, it also contributes to bone strength. A simple and tasty method to boost general health is to add lemon zest to meals.

Is Your Scan Safe? Research Ties CT Imaging to Increased Cancer Risk in U.S.

May 22, 2025 | 776 Views

Recent studies indicate that the frequency of CT scans may be linked to an increase in cancer cases in the U.S., possibly responsible for as much as 5% of annual diagnoses.CT scans utilize ionizing radiation, which may harm DNA and has the potential to cause cancer. According to the study, 93 million scans conducted in 2023 could lead to approximately 103,000 cancer cases, particularly impacting organs such as the lungs, colon, and breast. Although CT scans play a crucial role in diagnosing and managing serious health conditions, specialists advise caution regarding their overuse and recommend utilizing the lowest radiation dose that is effective. It is recommended that patients talk with their doctors about the need for scans and explore alternatives such as MRI or ultrasound when suitable, particularly in the case of children.

Breakthrough UTI Treatment: Plazomicin Now Available in India

May 21, 2025 | 696 Views

In India, plazomicin—a new antibiotic that can be injected once daily—has been introduced to address complicated urinary tract infections (cUTIs), particularly those stemming from multidrug-resistant bacteria. Due to increasing antimicrobial resistance (AMR), the incidence of cUTIs, which can result in severe conditions such as urosepsis, is on the rise. Men have a lower lifetime risk of UTIs (under 15%) compared to women (60%), but all UTIs in men are classified as complicated. The drug, initially developed by Achaogen and approved by the US FDA in 2018, is now marketed in India under the brand name Zemdri by Cipla. Plazomicin has shown effectiveness against Carbapenem-Resistant Enterobacteriaceae (CRE), offering hope amid failures of last-line antibiotics. This launch meets a vital healthcare requirement, with backing from the EPIC trial and data specific to India.

Take Charge of Your Brain Health: 5 Tips for Your 30s

May 20, 2025 | 780 Views

It is vital to concentrate on brain health in your 30s by taking up practices that promote lasting cognitive function. Essential nutrients such as omega-3 fatty acids, magnesium, coenzyme Q, and vitamin D are crucial for the brain, yet they are often absent from modern diets. These nutrients enhance memory, stabilize mood, and alleviate stress, thereby averting problems such as anxiety and memory lapses. Regularly engaging in activities such as acquiring new skills, reading, or mentally challenging yourself boosts neuroplasticity—the brain’s capacity to adapt and develop. During this decade, making deliberate lifestyle choices—such as ensuring a varied diet abundant in these nutrients and engaging your mind—sets the groundwork for healthier brain function in the years to come and contributes to overall mental well-being.

Why Trump’s Drug Price Order Is Unlikely to Shake India’s Pharma Sector

May 19, 2025 | 793 Views

The executive order from the Trump administration seeks to reduce U.S. prescription drug prices by as much as 80% using a “most favoured nation” (MFN) policy that links prices to those in other developed countries. The move has jolted global pharma markets, but Indian drugmakers are largely unaffected. The reason for this is that the policy focuses on expensive, patented medications, whereas Indian companies primarily export affordable generics. Experts point out that Indian generics are already priced competitively because of global market pressures. Despite the Indian pharmaceutical industry’s concern since March regarding potential retaliatory U.S. tariffs, the recent ruling does not affect its primary products. Indian pharmaceutical companies can relax—for the time being—as generics are not immediately affected.